申请人:——
公开号:US20030232807A1
公开(公告)日:2003-12-18
Novel piperazine and homopiperazine derivatives are agonists of melanocortin receptor(s) and are useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of the melanocortin receptors. The compounds of the present invention are therefore useful for treatment or prevention of diseases and disorders such as obesity, diabetes, and sexual dysfunction.
新型哌嗪和异哌嗪衍生物是黑色素皮质激素受体的激动剂,并可用于治疗、控制或预防对黑色素皮质激素受体激活敏感的疾病和紊乱。因此,本发明的化合物可用于治疗或预防肥胖、糖尿病和性功能障碍等疾病和紊乱。